<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17804">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02875106</url>
  </required_header>
  <id_info>
    <org_study_id>18796</org_study_id>
    <nct_id>NCT02875106</nct_id>
  </id_info>
  <brief_title>A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems</brief_title>
  <acronym>BAYathlon</acronym>
  <official_title>BAYathlon - a Digital Non-interventional AF Screening Study to Identify Commercial Pulse Detection Systems (CPDS) Detecting AF and Sinus Rhythm Parallel to ECG Recording Within Routine Clinical Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective in this study is to identify commercial pulse detection systems (CPDS)
      parallel to electrocardiogram (ECG) recording within routine clinical setting, which are
      able to detect atrial fibrillation or sinus rhythm of screened patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2017</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of correctly detected atrial fibrillation signals by CPDS in reference to ECG (sensitivity of CPDS).</measure>
    <time_frame>60 seconds</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of correctly detected sinus rhythm signals by CPDS in reference to ECG (sensitivity of CPDS).</measure>
    <time_frame>60 seconds</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <description>Adult female and male patients with diagnosed atrial fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
    <description>Adult female and male patients with diagnosed sinus rhythm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>12-point-ECG</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polar V800</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>360Â° eMotion FAROS SET + Belt</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adidas Micoach smart run</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TomTom Runner Cardio</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TomTom Runner Cardio HRM</intervention_name>
    <description>routine recording will be 60 seconds</description>
    <arm_group_label>Atrial Fibrillation Patients</arm_group_label>
    <arm_group_label>Sinus Rhythm Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients for whom the decision to record an ECG was made as per investigator's routine
        treatment practice
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult female and male patients with diagnosed atrial fibrillation or sinus rhythm in
             disease history

          -  Patients for whom the decision to record an ECG was made as per investigator's
             routine treatment practice

          -  Signed informed consent

        Exclusion Criteria:

          -  Patients participating in an investigational program with interventions outside of
             routine clinical practice
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bayer Clinical Trials Contact</last_name>
    <email>clinical-trials-contact@bayer.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Many Locations</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 1, 2017</lastchanged_date>
  <firstreceived_date>August 18, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sinus rhythm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
